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Abstract
Background: Severe brain injury is a leading cause of death and disability. Diagnosis and prognostication are diffi‑
cult, and errors occur often. Novel neuroimaging methods can improve diagnostic and prognostic accuracy, espe‑
cially in patients with prolonged disorders of consciousness (PDoC). Yet it is currently unknown how family caregivers
understand this information, raising ethical concerns that disclosure of neuroimaging results could result in therapeu‑
tic misconception or false hope.
Methods: To examine these ethical concerns, we conducted semi-structured interviews with caregivers of patients
with PDoC who were enrolled in a concurrent neuroimaging research program designed to detect covert conscious‑
ness following severe brain injury. Caregivers held surrogate decision-making status for a patient. Interviews were
conducted at two time points for each caregiver. The first interview occurred before the disclosure of neuroimaging
results. The second occurred after disclosure. Descriptive analysis was applied to the data of four interview topics: (1)
expectations for neuroimaging; (2) reactions to evidence of preserved cognition; (3) reactions to null results; and (4)
understanding of the results and study.
Results: Twelve caregivers participated in the study; two caregivers shared surrogate decision-making status for
one patient with PDoC. Twenty-one interviews were completed; one caregiver declined to participate in the postdisclosure interview. Three patients with PDoC associated with the study displayed evidence of covert consciousness.
Overall, caregivers understood the neuroimaging research and results. Caregivers who received results of covert
consciousness were generally pleased. However, there was some variation in expectations and reactions to these data
and null results.
Conclusion: This study, for the first time, reveals caregiver expectations for and reactions to neuroimaging evidence
of covert consciousness in patients with PDoC. Caregivers understood the neuroimaging research and results, casting
doubt on speculative ethical concerns regarding therapeutic misconception and false hope. However, disclosure of
neuroimaging result could be improved. Pre-disclosure consultations might assist professionals in shaping caregiver
expectations. Standardization of disclosure might also improve comprehension of the results.
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Background
Brain injury is medically challenging and places significant burdens on family caregivers (hereafter, “caregivers”) and health systems. Severe brain injury can lead to
prolonged disorders of consciousness (PDoC), such as
the vegetative state (VS) and minimally conscious state
(MCS). Diagnosis and prognostication of patients with
PDoC is difficult. Misdiagnosis occurs often and caregivers frequently make ethically fraught decisions, such as
whether to continue life-sustaining treatment, under
conditions of uncertainty.
Recent advances in neurology might improve diagnosis and prognostication in some patients with PDoC.
Researchers have developed functional magnetic resonance imaging (fMRI) and electroencephalography (EEG)
methods that improve diagnostic and prognostic accuracy following severe brain injury [1–3]. Some studies
demonstrate that brain responsiveness to auditory stimuli predicts recovery [4, 5]. Other studies demonstrate
that some patients clinically diagnosed as being in a vegetative state can willfully modulate their brain activity to
command, indicating that they are aware [6–9]. These
patients are regarded as “covertly conscious” or as having “cognitive motor dissociation”— their consciousness
is manifest in their brain activity, not their overt behavior,
and neuroimaging is the only way to detect it [10, 11].
The evidence base for these methods is relatively nascent and they are still used predominantly in the research
setting. However, several key developments in neurology practice guidelines have occurred over the past
three years, signaling that fMRI and EEG assessment of
patients with PDoC might soon be incorporated in clinical practice. The 2018 U.S. practice guideline update on
disorders of consciousness recommends that such methods may be used for prognostication or if diagnosis with
serial clinical examination remains ambiguous [12]. In
2020, the European Academy of Neurology made similar
recommendations about the potential benefit of routine
fMRI and EEG assessment in patients with PDoC [13].
Despite these advancements, disclosure of neuroimaging results of covert consciousness remains an area of
intense ethical debate. In the research setting, ethicists
worry that disclosure could lead to therapeutic misconception [14]. Fins and colleagues, for example, “caution
against suggesting therapeutic intent when there is none
and thus fostering a therapeutic misconception” [14, page
9]. They go on to stress that “actively disabusing surrogates of such misconceptions” should be a “an even

stronger goal” of research programs using these methods.
Similarly, ethicists also argue that, once these methods
are translated into clinical practice, they could negatively
impact decision making in the early phase of recovery.
Caregivers could develop false hope in a positive outcome
and might miss the “window of opportunity” to withdraw
life-sustaining treatment (e.g., [15]). These arguments
reflect a shared concern that, in both the research and
clinical settings, caregivers of patients with PDoC might
be emotionally vulnerable and misunderstand the results.
Complex neuroimaging data could be difficult to process,
leading caregivers to reason “beyond the evidence” and
make poorly informed clinical decisions.
These arguments highlight important considerations
for researchers and physicians. However, many of these
claims are speculative. The fact that disclosure of neuroimaging evidence of covert consciousness could lead to
therapeutic misconception or false hope does not mean
that it will. Contrary to these cautionary claims, we have
argued that neuroimaging results ought to be disclosed
to caregivers, provided that four conditions are met [16].
First, disclosure should not undermine the scientific
validity of the study. Second, the results must be informative and reliable. Third, the benefits of disclosure must
outweigh potential harms. And fourth, caregivers must
consent to disclosure. However, caregivers’ expectations
for and experiences of disclosure—particularly in how
they understand the benefits, harms, and informativeness
of neuroimaging data—are still poorly understood.
In this article, we present findings from a qualitative
interview study that assessed caregivers’ expectations for
and experiences of multi-modal neuroimaging research
to detect covert consciousness in patients with PDoC.
One previous study has examined this issue [17], but the
study focused on EEG assessment in the European context, and the retrospective design limited examination of
participant attitudes [18]. By contrast, our study prospectively examined participant attitudes as caregivers progressed through the neuroimaging process.
Our study is part of a four-year research program on
the ethics of neuroimaging following severe brain injury
[19]. This program was, in part, guided by four research
questions: 1) What are caregivers expectations for enrolling in neuroimaging research?; 2) How do caregivers
react to evidence of covert consciousness?; 3) How do
caregivers react to uninformative neuroimaging results?;
and 4) Do caregivers generally understand the research
and results? These research questions are informed by

EEG and fMRI To determine whether somatosensory functions can serve as proxies for covert
consciousness as compared to fMRI or clinical evaluation

fMRI

Gibson et al. [26]

Naci et al. (27)

To determine whether fMRI can detect covert consciousness with naturalistic
stimuli (e.g., viewing a movie)

To determine whether event-related potentials can detect preserved auditory
processing

EEG

Beukema et al. [4]

Purpose of study

To determine whether fMRI can detect selective attention command following
and communication

Modality

Naci and Owen [25] fMRI

Study

Table 1 Selected neuroimaging studies in which patients were enrolled

A model of cognitive changes during movie viewing was developed in healthy
participants. Cognitive changes in one patient with PDoC were identical to
those in the model while viewing the movie

Only those patients with PDoC who were capable of fMRI or behavioral com‑
mand following also demonstrated relevant somatosensory functions

All enrolled patients with PDoC (N = 16) showed preserved auditory processing.
Seven showed differentiated speech from noise

Three patients with PDoC were capable of selective attention command follow‑
ing. Two of these patients also responded correctly to yes/no questions

Main outcome
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the ethical concerns of therapeutic misconception and
false hope, outlined above. Empirical assessment of caregivers’ experiences might clarify these ethical debates,
improve the disclosure of neuroimaging results, and optimize physician-caregiver communication as these methods are translated into clinical practice.

with PDoC, and who had cared for the patient for at least
six months. Consistent with established qualitative methods [28], we recruited and interviewed participants until
thematic saturation was reached, the point at which no
new qualitative themes emerge from the interview data.

Methods

An interview guide was developed by our research
team (LGL, AMO, AP, FW, CW) based on a literature
review and expert knowledge of themes of interest (see
Additional file 2: interview guide). Themes of interest included the history of the brain injury, reasons for
enrolling in the neuroimaging research, reactions to evidence of preserved cognition or null results, changes in
caregiver or clinician behavior, and the overall experience
of the neuroimaging research program. Interviews were
digitally recorded and professionally transcribed.
Semi-structured interviews were performed by an
experienced qualitative researcher (SM). We conducted
two interviews for each participant. The first interview
occurred prior to the disclosure of neuroimaging results.
The second occurred within two months after disclosure.
The interview guide contained pre- and post-disclosure
questions to assess changes in caregiver attitudes. The
time intervals between interviews, neuroimaging, and
disclosure were variable due to scheduling constraints
and neuroimaging unit availability. However, no participant interview was conducted more than two months
before neuroimaging or two months after the disclosure
of results.
Data collection and analysis were iterative and concurrent. Four members (LGL, SM, FW, CW) of our
interdisciplinary team independently read and coded
transcripts before regularly scheduled discussions. The
interview guide was then adapted to new insights and
themes that emerged from each interview. Through dialogue, team members developed codes that described
the meaning units of the qualitative data. Open coding
was first applied so identified codes were descriptive
and grounded in the data. A coding framework was then
developed and applied across all transcripts using the
software, NVivo-10. Axial coding was used to compare
relationships between codes. For this article, a descriptive
analysis was applied to the interview data related to our
research questions: 1) caregiver expectations for neuroimaging; 2) caregiver reactions to neuroimaging evidence
of preserved cognition; 3) caregiver reactions to null
results; and 4) caregiver understanding of the results and
study. The analysis was reviewed by four members of the
research team for accuracy (LGL, AP, FW, CW).

Research context

We recruited caregivers of patients with PDoC from a
concurrent neuroimaging research program at the Owen
Lab at the University of Western Ontario, an internationally recognized center for brain injury research. Patients
assessed by the Owen Lab include individuals clinically
diagnosed as being in the VS, MCS, or locked in syndrome (LIS). The VS is a neurological condition characterized by wakeful unresponsiveness [20, 21]. The MCS
is characterized by wakefulness with intermittent behavioral responsiveness to visual, auditory, tactile, or noxious stimuli [22]. The LIS is characterized by whole body
paralysis but preserved cognitive function [23]. Patients
with these conditions have profound motor impairments,
which can conceal preserved cognition during clinical
examination. To verify clinical diagnosis, patients were
repeatedly assessed with the JFK-Coma Recovery ScaleRevised [24] when they visited the lab.
Patients with PDoC whose caregivers were enrolled in
our interview study underwent a variety of neuroimaging tests, including fMRI scans and EEG recordings (see
Table 1). The neuroimaging tests were designed to detect
preserved cognitive functions following brain injury—
such as basic executive and auditory functions—or the
capacity to volitionally modulate brain activity to command. A lab coordinator (LGL), with PhD training in
brain injury, guided caregivers through the neuroimaging
research. Neuroimaging results were disclosed to caregivers by the lab PI (AMO) and lab coordinator (LGL).
The disclosure process included a results document and
phone consultation, with opportunities for follow-up
discussion. Identical results documents were sent to the
referring physician and the caregiver.
The results document contained descriptions of the
neuroimaging tests, patient responses, and interpretations of the responses (see Additional file 1). The majority
of the document described the results in lay terms, while
portions were written in more technical language for
referring physicians.
Participants

Caregivers of patients with PDoC were sequentially
recruited from the concurrent neuroimaging research
at the Owen Lab. We interviewed caregivers who spoke
English, were surrogate decision makers for the patient

Data collection
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Results
Twelve caregivers (eight self-identified as female) of
eleven patients with PDoC participated in the study
(Table 2). Seven caregivers were parents, four were
spouses, and one was a sibling. All caregivers were Canadian residents and interacted with provincial health systems when managing benefits and care for patients. Six
patients with PDoC were clinically diagnosed as being in
the VS (P1, P4, P6, P8, P10, P11), one was clinically diagnosed as being in the MCS (P2), three alternated between
the VS, MCS, and emergence from the MCS (P3, P5, P9),
and one was clinically diagnosed as being in the LIS (P7).
The average time since injury was 5.49 years (SD = 7.14).
The parents of one patient reported that his fiancée acted
as the primary caregiver and surrogate decision maker
after injury, but later relinquished this role to them. All
other caregivers had been serving in this role since the
patient’s initial injury.
We conducted eleven pre-disclosure interviews and ten
post-disclosure interviews between 2015 and 2016. Two
family caregivers (P91 and P92) shared surrogate decision-making status for one patient, reducing the overall

number of interviews. An additional family caregiver
(P11) did not respond to requests for a post-disclosure
interview. This caregiver’s pre-disclosure interview was
emotionally difficult; we believe she withdrew from the
study due to the emotions arising from discussing the
patient’s accident. Representative quotes from participants are labeled with the participant number and “a” for
pre-disclosure interview or “b” for post-disclosure interview, e.g., P1a or P1b.
Within the four above-outlined interview topics, we
identified various themes across caregivers (Table 3).
First, we observed that caregivers had a spectrum of
expectations for the neuroimaging research, ranging
from hopeful to conflicted expectations for the results.
Some caregivers were glad to participate in a study that
might improve the care of future patients, while others
wanted to correct what they perceived as a misdiagnosis
of the patient. Second, we observed that caregiver reactions to the neuroimaging evidence of preserved cognition were multifaceted. Caregivers were often pleased
with this information, but some found it difficult to
process and share with their extended family. Third,

Table 2 Caregiver and patient characteristics
Caregiver Relation to patient Clinical
diagnosis of
patient

Time since injury Main neuroimaging results

Covert consciousness

No evidence

P1

Spouse

VS

5 yrs

No significant findings with EEG or fMRI

P2

Mother

MCS

4.1 yrs

EEG revealed basic attentional capacity. fMRI data had No evidence
movement artifacts and no conclusions could be
drawn

P3

Father

VS/MCS

17 yrs

EEG revealed basic attentional capacity and speech
versus noise distinction. fMRI revealed visual and
executive functions, and selective attention com‑
mand following*

+

P4

Spouse

VS

1.2 yr

No significant findings with EEG. No fMRI tests
performed

No evidence

P5

Spouse

VS/MCS

3.1 yrs

EEG revealed speech from noise distinction. fMRI
revealed capacity for selective attention command
following*

+

P6

Mother

VS

22 yrs

EEG revealed attentional capacity. fMRI revealed
capacity for mental imagery*, selective attention
command following*, and communication*

+

P7

Spouse

LIS

1 yr

EEG revealed basic attentional capacity. No fMRI tests
were performed

Not evaluated due to
clinical diagnosis

P8

Mother

VS

1 yr

EEG data had movement artifacts and no conclusions
could be drawn. No fMRI tests were performed

No evidence

P91 & P92

Father/Sibling

MCS/EMCS

1 yr

EEG revealed basic attentional capacity. No fMRI tests
were performed

No evidence

P10

Father

VS

3 yrs

No significant findings with EEG. No fMRI tests were
performed

No evidence

P11

Mother

VS

2 yrs

No significant findings with EEG. fMRI data had move‑ No evidence
ment artifacts and no conclusions could be drawn

VS = Vegetative State; MCS = Minimally Conscious State; EMCS = Emergence from the Minimally Conscious State; EEG = Electroencephalography; fMRI = Functional
Magnetic Resonance Imaging. All clinical diagnoses are derived from repeated evaluation with the CRS-R. Main neuroimaging results column summarizes the
disclosure letter provided to caregivers. * denotes neuroimaging evidence of covert consciousness. Neuroimaging results are derived from research outlined in Table 1

Caregivers displayed a spectrum of expectations for the neuroimaging
research, ranging from hopeful to conflicted expectations. In some
cases, these expectations appeared to bear on caregivers’ acceptance of
the neuroimaging results

Expectations for neuroimaging

Caregivers were either accepting or resistant to null results. Caregivers
“What I do with [patient] from a sensory stimulation perspective is a lot
who were resistant challenged the validity of the neuroimaging meth‑
more in-depth and aggressive, because I use acupressure therapy and
ods. In contrast, no caregiver who received evidence of preserved cogni‑
muscle stimulation. They didn’t do anything like smell stimulation. I do
tion challenged the results. Some caregivers also expressed emotional
that all the time, and I see a significant amount of reaction to that.” (P1b)
distress in the face of continued uncertainty
“I have to know what’s going on so I could provide whatever my son
needs. I just wanted to know if my son was in pain. I still feel the same.
I’m lost and I’m drained.” (P10b)
Caregivers generally understood the neuroimaging research and results.
“They’re learning more about the brain, so it’s a matter of how people are
If caregivers initially misunderstood the results, they felt comfortable ask‑
treated. I think down the road there’s a lot of hope for different technolo‑
ing questions of the neuroimaging research team
gies. And that will change how people are treated.” (P3b)
“I didn’t understand a lot, [but] when I spoke to [researcher] she broke it
down and said, ‘Okay, this is what it is. There was some type of activity.’”
(P5b)

Understanding of the results and study

“I’m talking to him more as an adult now. He doesn’t want to be talked to
like a teenager. The more you understand, the more you know what he
understands, and maybe by talking to him at a more adult level it helps
him too.” (P3b)
“[My in-laws equated] there was brain activity with he’s waking up tomor‑
row.” (P5b)

“My hope is that this will help research understand that he wasn’t a vegeta‑
tive brain, he wasn’t dead. Number one, that diagnosis was wrong, 100%.
It was wrong.” (P1a)
“The testing maybe would benefit [patient] in that people will have a better
understanding of his brain function […] But that’s about it. I mean, it’s
research, right?” (P2a)

Representative quotes

Reactions to null results

Reactions to evidence of preserved cognition Caregiver reactions to neuroimaging evidence of preserved cognition
were multifaceted. Caregivers were often pleased with this information,
but some found it difficult to process and share with others

General finding

Interview topic

Table 3 Summary findings
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we observed that caregivers were either accepting or
resistant to null results. Caregivers who were resistant
challenged the validity of the neuroimaging methods.
In some cases, caregivers believed that their personal
assessments were more accurate than those used by the
Owen lab. Finally, we observed that caregivers generally understood the neuroimaging research and results.
Caregivers reported that, even if they didn’t understand
initially, they felt comfortable interacting with the neuroimaging research team and asking questions.
Below, we describe these topics in detail. The interview
topics track the experiences of caregivers as patients progressed through the neuroimaging research program.
Data from other interview topics, such as caregiver experiences with health systems and caregiver burden, are
reported in Munce et al. [29] and Gonzalez-Lara et al.
[30], respectively.
Caregiver expectations

Caregiver expectations for neuroimaging were complex,
ranging from hope for the detection of preserved cognition to a more guarded outlook. Some caregiver expectations were shaped by a desire to correct what they
perceived as diagnostic errors made by the patient’s primary care team. These disagreements often centered on
a patient’s medical status. However, in some cases, caregivers also appeared to have differing beliefs about the
meaning of consciousness and personhood relative to
clinicians. The value of neuroimaging for these caregivers was to gain information that confirmed their beliefs
and contribute to research that will mitigate these disagreements in the future. For example, one caregiver
firmly believed that her spouse was misdiagnosed: “My
hope is that this will help research understand that he
wasn’t a vegetative brain, he wasn’t dead. Number one,
that diagnosis was wrong, 100%. It was wrong.” (P1a) This
patient was assessed multiple times, but no evidence of
preserved cognition was observed. As we review below,
lack of evidence of preserved cognition does not rule out
the possibility of covert consciousness. Yet, lack of evidence could still be disappointing in light of these strong
expectations.
In contrast, other participants expressed more guarded
expectations. For example, one caregiver acknowledged
the limits of neuroimaging when her son was examined.
She expressed hope, but also the importance of being
realistic: “The testing maybe would benefit [patient] in
that people will have a better understanding of his brain
function […] But that’s about it. I mean, it’s research,
right?” (P2a) This patient was clinically diagnosed as
being in the minimally conscious state, suggesting that
there might be a response to neuroimaging tests. However, EEG assessment showed only sparse evidence of
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attentional capacities, and no conclusions could be drawn
from the fMRI data.
Additionally, some caregivers’ expectations related to
a patient’s cognitive functions. One caregiver described
his curiosity regarding “what [his spouse] was thinking.”
He wanted to know whether: “My speech, my verbal, my
sound, songs, anything that different parts of the brain
were responding to.” (P4a) This caregiver’s attitude could
represent broader expectations that neuroimaging might
justify his caregiving efforts have been beneficial. If neuroimaging revealed that his spouse retained certain perceptual capacities, he might feel justified in his decision
to continue rehabilitation, or decisions in daily interactions, such as speaking or reading to her.
Caregiver reactions to evidence of preserved cognition

“Evidence of preserved cognition” describes neuroimaging data that indicate a response to experimental stimuli,
ranging from basic attentional capacities to volitional
mental imagery. This evidence may suggest that patients
are covertly conscious despite their clinical diagnosis. Of
the patients with PDoC associated with this study, three
showed definitive evidence of covert consciousness (P3,
P5, P6), while three further patients showed evidence
of basic attentional capacities (P2, P7, P9). Evidence of
basic attentional capacities, while important for understanding the patient’s preserved cognition, is ultimately
insufficient to conclude whether covert consciousness is
present. In describing caregiver reactions below, we distinguish between evidence of covert consciousness and
evidence of basic attentional capacities.
Caregivers who received evidence of covert consciousness reflected on the benefit of having new—and
confirming—information that the patient was aware.
A recurring theme was that these results might change
behaviors toward the patient. For example, a father
described how evidence of covert consciousness motivated him to treat his son as an adult, rather than a teenager—the age at which he sustained his brain injury: “I’m
talking to him more as an adult now. He doesn’t want to
be talked to like a teenager. The more you understand, the
more you know what he understands, and maybe by talking to him at a more adult level it helps him too.” (P3b)
This father’s observations suggest that aspects of his relationship with his son were anchored to the time of injury.
Neuroimaging data appeared to beneficially disrupt these
assumptions.
This father also noted how he planned to use the neuroimaging data to shape interactions with clinicians.
Newer clinical staff, he observed: “Don’t know him that
well, but I think [the results] are going to help how they
communicate. Instead of talking to him like a baby, they’ll
talk to him like a 36-year-old man, like he is.” (P3b) This
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father’s experience also appeared colored by the discovery of his son’s personhood and what that implied for
caregivers in similar situations: “They’re people inside,
right? Even though I believed that he understood all
along, [the results] reinforced what I believe. Maybe I’m
babying him too much, you know?” (P3b).
Another caregiver who received EEG results of attentional capacities reflected on how the data provided
insight on the kinds of experiences her spouse could have,
even though they did not confirm covert consciousness:
Now I know at what level I can do stuff with my husband. If I read to him or if I watch a movie with him,
my thought in the past was ‘Does he understand?
Does he get what I’m saying?’ But now I know he
does. So, I’m like, ‘Okay, then he’s obviously in there.’
(P7b)
Notably, this caregiver’s observations highlight the
utility of neuroimaging assessment in patients who are
already known to be conscious. Her spouse’s clinical
diagnosis, the LIS, implied that he was conscious but
unable to move his body. This caregiver found value in
neuroimaging data in that it revealed the kinds of perceptual experiences her spouse could have.
Caregivers who received evidence of covert consciousness also reflected on the positive feeling of having
their beliefs about a patient validated. These caregivers reported dismissiveness or skepticism from clinicians, friends, and extended family when they broached
the topic of preserved cognition. The neuroimaging data
affirmed their beliefs and, in some cases, allowed caregivers to constructively return to these difficult conversations. For example, one mother who received evidence of
covert consciousness stated: “We like to tell people who
might have been a little dubious. It’s a positive feeling.
People are more supportive.” (P6b).
Although most caregivers were pleased to receive
evidence of preserved cognition, some expressed disappointment that the neuroimaging data fell short of
explaining the cause of injury. The spouse of the patient
diagnosed as being in the LIS, described above, noted
that she wished the research team could have explained
why her spouse’s stroke occurred. “I will never have that
answer,” she stated: “When the results all came back, I
was really happy. But then on the flip side I’m like, why
did this happen?” (P7b). This caregiver acknowledged
that the neuroimaging methods were not designed to
yield this information. Nevertheless, her spouse’s brain
injury left her with unanswered questions that framed
her understanding of the neuroimaging research and
results.
Another caregiver reflected on the difficulty of sharing
the results with her children and in-laws. This caregiver
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was happy to receive evidence of covert consciousness,
but this information was difficult to convey to others,
and ultimately resulted in interfamily stress. “You always
want to hear more than what you get,” she stated: “[My
children] asked me questions, and I would say, ‘I don’t
even know,’ and they’d question, ‘Why don’t you know,
Mom?’ ‘This is Dad. How come you don’t know?’” (P5b)
She noted further that her in-laws equated “there was
brain activity” with “he’s waking up tomorrow,” a common misunderstanding about the prognostic value of
these results. This reaction underscores how different
family members might attribute varying—even conflicting—meanings to the same neuroimaging data.
Caregiver reactions to null results

“Null results” describe neuroimaging data that are uninformative. Lack of a neural response does not imply that
a patient is unconscious. A conscious patient might fail to
understand the task instructions, have auditory impairments, or fall asleep during the test leading to a false
negative result. As true negative and false negative results
are indistinguishable, the neuroimaging research team
framed these results as “null” or “uninformative” during
disclosure.
Caregivers who accepted null results appeared to do
so for two reasons. First, some appeared to have come to
terms with a patient’s condition. For example, one caregiver of a patient who was clinically diagnosed as being
in a VS (P4b) said that he “knew from day one” that he’d
likely receive null results. It is unclear whether this reaction was related to the length of time the patient was in
a VS. This caregiver’s spouse was in a VS for 1.2 years,
while other caregivers whose spouses or children had
been in a PDoC for much longer were ultimately resistant
to null results.
A second reason why caregivers appeared accepting
of null results is that they understood potential technical failures in the neuroimaging process. One caregiver
stated, for instance: “I had a chat with [the research
team], just before Christmas, and as I suspected the
results are very inconclusive because [patient] moved too
much during the MRI. It wasn’t a big, ‘Oh, my goodness’
surprise, to be honest. But anyway, it’s been worth a go.”
(P2b).
In contrast to caregivers who were resigned to null
results, others refused to accept the results and challenged the validity of the neuroimaging tests. One caregiver, who was adamant that her spouse was responsive
at home, was quick to dismiss the tests as mere “research”
interventions. She stated: “What they do in research is
not final, right?” (P1b) This caregiver continued to challenge the validity of neuroimaging, arguing that the sensory stimulation she performs is more sensitive than the
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tests used in the Owen lab. For this caregiver, neuroimaging did not compare with the daily attention she provided
to the patient. She observed further:
What I do with [patient] from a sensory stimulation perspective is a lot more in-depth and aggressive, because I use acupressure therapy and muscle
stimulation. They didn’t do anything like smell stimulation. I do that all the time, and I see a significant
amount of reaction to that. (P1b)
She also expressed disappointment at not receiving
more information about alternative research interventions: “I asked about transcranial stimulation, I asked
about different therapies that could help with brain activity. Not that I should expect anything, but I thought
somebody in that field might have an idea of other kinds
of therapy that could be tried.” (P1b) Interestingly, this
caregiver’s observation does not accurately reflect how
the Owen lab discusses research results. During disclosure, it is common to provide evidence-based recommendations or to invite caregivers to enroll patients in
future studies. However, the research team carefully
avoids discussion of unproven interventions. At the time
of disclosure, there was no evidence that transcranial
stimulation would benefit this patient.
Finally, some caregivers’ reactions revealed emotional exhaustion in the face of continuing uncertainty.
The father of one patient who received null results was
accepting of them, but ultimately expressed disappointment in not knowing if his son was in pain: “I have
to know what’s going on so I could provide whatever my
son needs. I just wanted to know if my son was in pain. I
still feel the same. I’m lost and I’m drained.” (P10b).
Caregiver understanding of the study and results

Overall, caregivers appeared to understand the neuroimaging research program and the results. One caregiver
acknowledged that, although she didn’t understand the
“highly technical stuff,” she still “understood enough to
feel very comfortable with what was going on” (P6b).
Caregivers also understood the potential benefit of the
neuroimaging research. A father, whose son had been
in a PDoC for 17 years, stated: “They’re learning more
about the brain, so it’s a matter of how people are treated.
I think down the road there’s a lot of hope for different technologies. And that will change how people are
treated.” (P3b).
Although caregivers appeared to generally understand the neuroimaging research, we observed variation
in how they described and attributed meaning to the
results. A key theme among several caregivers was the
use of the phrases “there is activity” and “brain activation.” For example, one caregiver recalled her experience
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of hearing the word “activity” during the disclosure consultation. She stated: “All I had in my mind was, ‘Okay,
there’s activity.’ And a lot of things got blocked out.
I didn’t want to hear anything else.” (P5b) Notably, the
information this caregiver “blocked out” and “didn’t want
to hear” pertained to technical features of the neuroimaging tests. The term “activity” was the focal point of her
understanding.
One caregiver also stated that she wished she knew
more about the experimental stimulus. This caregiver’s
son underwent a naturalistic stimuli test (see Table 1,
Naci et al. 2014). The test used a short audio clip from
the movie, Taken, to evoke a neural marker of executive
processing and suspense. The film was discussed during
the informed consent process, however the caregiver was
unfamiliar with it:
I would have liked to have been able to hear what
[patient] was hearing. We weren’t familiar with the
[movie ‘Taken’]. My husband Googled it later and
found that it was a very violent movie with profanity. [Patient] didn’t live a sheltered life, but I thought
if it was being traumatic to him emotionally, if it
was really violent or vulgar or there were things that
were really agitating him inside, how would we know
if we’re not hearing? (P8b)
The neuroimaging data from this patient contained
movement artifacts, potentially from agitation while the
patient was in the scanner. Although the audio clip used
in the study does not contain profanity or violence, the
caregiver might have reasonably thought that the stimulus caused this agitation.
While there was variation in caregiver understanding of
the results, many were quick to contextualize their beliefs
in light of positive experiences with the neuroimaging
research team. Caregivers reported feeling neglected by
the health system; they believed that patients with PDoC
were not treated as persons and received suboptimal
care. In contrast, caregivers reported that the neuroimaging research team treated patients with respect. Indeed,
one caregiver who received null results recalled the interaction with a research team member:
He said, ‘I just want to prepare you all in advance
this is only a research test.’ And I turned around and
I looked at him and I said, ‘You know what, Doctor?
Just the fact that you have come all the way to do the
test, that’s all I can be thankful for. Doesn’t matter
what the results are.’ (P1b)
Additionally, caregivers also highlighted the neuroimaging research team’s systematic approach to discussing
the results. This appears to have tempered expectations
and increased comprehension. One caregiver stated: “I

Peterson et al. BMC Med Ethics

(2021) 22:105

didn’t understand a lot, [but] when I spoke to [researcher]
she broke it down and said, ‘Okay, this is what it is. There
was some type of activity.’” (P5b) Similarly, the caregiver
who expressed concern about the test intervention,
described above, still praised the neuroimaging research
team: “I was very impressed with [researcher]. He was
very easy to talk to, you know what I mean? He wasn’t
gruff and cold, he just seemed very warm and personable,
so that was positive.” (P8b) The neuroimaging research
team’s efforts to earn trust, rather than expect it, appears
to have enhanced their relationship with caregivers and
the quality of the disclosure process.

Discussion
This study reports, for the first time, preliminary insight
on the expectations and experiences of caregivers of
patients with PDoC when they receive neuroimaging results of covert consciousness in the research context. Overall, caregivers appeared to understand the
neuroimaging research, had positive experiences with
the neuroimaging research team, and found the results
valuable. These findings cast doubt on speculative ethical concerns regarding therapeutic misconception and
false hope. While it is possible that therapeutic misconception or false hope could arise from the disclosure
of complex neuroimaging data following severe brain
injury, our study did not detect these attitudes among our
participants.
Although our findings contradict these cautionary ethical arguments, we did observe complexities in caregiver
expectations, the meaning attributed to neuroimaging
results, and the effect of interactions with the neuroimaging research team. One critical issue was the potential
for disagreement between caregivers and researchers
regarding the neuroimaging results. Some caregivers
who received null results disagreed with the findings and
the validity of the neuroimaging tests. In contrast, no
caregiver who received results of covert consciousness
disagreed with the findings. Previous qualitative research
details similar findings. Schembs et al. observed that,
when next-of-kin disagree with EEG results acquired
from a patient with PDoC, they might also dismiss the
validity of the neuroimaging test [17, 18]. Crucially,
Schembs et al. also observed that caregiver disagreement
was linked to receipt of null results, not evidence of covert consciousness.
Additionally, we also observed that some caregivers
approached the neuroimaging research through the lens
of their own lay vocabulary or conceptual framework.
Lay vocabularies and conceptual frameworks related to
brain injury did not appear to impede caregiver understanding of the results, in part, due to ongoing counseling
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provided by the neuroimaging research team. However, previous qualitative research has identified this as
a potential contributor to communication breakdown.
Edgar et al. observed that clinicians use “a medical science framework” to describe the status of patients with
PDoC, which constructs “the patient in terms of measurable physical parameters.” Family members, by contrast,
use an “interpretative framework that encompasses the
uniqueness of the patient and the relative’s relationship to
them” [31]. Failure to recognize this difference can lead
to “pathologizing” interactions with caregivers [32].
We did not observe these negative interactions. However, we acknowledge that there could be discrepancies in
the ways that caregivers and health professionals understand—or misunderstand—the neuroimaging data upon
disclosure. First, caregivers might fail to understand the
neuroimaging intervention (or the experimental design).
One caregiver in our study (P8b), for example, explained
that she wished she knew more about the auditory stimulus from the film, Taken. This caregiver’s misunderstanding was eventually corrected with further information,
but the discrepancy highlights potential failures in the
informed consent process.
Second, caregivers might fail to understand the rigor
and validity of the neuroimaging tests. This misunderstanding could emerge alongside strong expectations for
evidence of covert consciousness (e.g., in our study, P1b).
These caregivers likely understand the neuroimaging
procedure, the results, and their potential clinical value.
Yet they may ultimately misunderstand the degree of certainty that should be placed on the neuroimaging data.
Third, caregivers might fail to understand the diagnostic or prognostic utility of the neuroimaging data.
In our study, for instance, one caregiver (P5b) reflected
on how her in-laws—the patient’s parents—equated
observed brain activity with recovery. The caregiver’s
in-laws ultimately reasoned “beyond the evidence” by
attributing greater prognostic value to the neuroimaging data. Importantly, the caregiver’s in-laws were one
step removed from the disclosure process, and so their
understanding of the results was out of the control of the
neuroimaging research team. Nonetheless, this kind of
family dynamic might still indirectly impact clinical decision making, and health professionals should be prepared
for these situations.
Finally, health professionals themselves might also misunderstand caregivers’ conceptualizations of the neuroimaging results and associated goals of care. As described
above, a caregiver’s understanding of a patient’s conditions is often embedded in ongoing and complex familial relationships. This understanding, however, might not
cohere with received medical wisdom. Failure of health
professionals to acknowledge this alternative way of
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understanding a patient’s condition can undermine trust
with caregivers, and potentially interfere with clinical
decision making for the patient.
In light of these variations in understanding neuroimaging evidence of covert consciousness, we outline below
two steps that might improve the disclosure process in
both research and clinical settings. First, prior to disclosing neuroimaging results, professionals should endeavor
to understand caregiver values and the language they use
to describe a patient’s condition. These pre-disclosure
discussions might prevent misunderstandings between
caregivers and professionals [33]. Professionals needn’t
acquiesce to caregiver beliefs about patients with PDoC
that are inconsistent with scientific facts. However,
acknowledging caregiver views could lead to better communication. Updated clinical guidelines on PDoC explicitly recommend that physicians familiarize themselves
with patient and family values to improve counseling on
high-stakes decisions [12].
Second, disclosure of neuroimaging results to caregivers should be standardized, involve professionals who are
trained in communication, and allow sufficient time for
questions and discussion [10, 34, 35]. These mechanisms
are intended to mitigate disagreement, improve caregiver
comprehension of the results, and potentially optimize
decision making.
Standardized disclosure procedures might be adapted
from cognate fields, such as Alzheimer’s disease (AD)
research. Disclosure standards for PET imaging data suggestive of a pre-clinical AD diagnosis could be instructive. Harkins et al. developed a method for disclosing
these results to mitigate detrimental emotional responses
and caregiver/patient misunderstanding [36]. This procedure involves pre- and post-disclosure educational
interventions to temper expectations. Patients and caregivers are also assessed for the impact of disclosure on
their wellbeing and willingness to learn new information.
There are relevant disanalogies between the disclosure
of a pre-clinical AD diagnosis and evidence of covert
consciousness following severe brain injury. However,
the procedure for standardizing disclosure of neuroimaging results could be a first step for the PDoC research
community.

Limitations
Our study has several limitations. First, although our
study reached thematic saturation, only three patients
cared for by interview participants displayed evidence of
covert consciousness. This may have impacted the variation in our observations of caregiver reactions to neuroimaging results. Moreover, we were unable to compare
these reactions across caregiver types. Caregiver age,
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relationship to patient, self-reported gender, and duration of condition might impact their expectations and
understanding.
Second, caregivers who seek out assessment at the
Owen Lab are often familiar with the lab’s research from
popular press coverage. This could bias caregiver understanding of neuroimaging results or lead to unrealistic
expectations. We did not observe this in our study, but
biases could be undetected.
Third, we interviewed caregivers of patients with PDoC
who underwent a battery of neuroimaging tests, not a
single test. Specific tests were not used in some patients
due to agitation, metal implants, or the inability to be in
a prone position for a scan. We could not assess caregiver
attitudes toward particular neuroimaging tests.

Conclusion
This study reports, for the first time, the expectations and
experiences of caregivers of patients with PDoC as they
undergo neuroimaging research to detect covert consciousness. Overall, caregivers appeared to understand
the neuroimaging research and results, casting doubt on
speculative ethical concerns regarding therapeutic misconception and false hope. Nonetheless, we observed that
some caregiver expectations deviated from the neuroimaging results, raising the potential for disagreement. We
identified two avenues that could improve the disclosure
process: supporting trust-building interactions among
caregivers, clinicians, and researchers, and standardizing disclosure procedures. Attention to the experiences
of caregivers, their understanding of neuroimaging, and
how it is mediated by their interactions with researchers
and clinicians, could lead to improved communication of
neuroimaging results following severe brain injury.
Abbreviations
PDoC: Prolonged disorder of consciousness; EEG: Electroencephalography;
fMRI: Functional magnetic resonance imaging; PET: Positron emissions tomog‑
raphy; VS: Vegetative state; MCS: Minimally conscious state; EMCS: Emergent
from minimally conscious state; ICU: Intensive care unit.

Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s12910-021-00674-8.
Additional file 1. Sample disclosure letter.
Additional file 2. Interview guide.
Acknowledgements
We thank the participants who enrolled in this study; they are supporting the
growth of scientific knowledge critical to improving the lives of patients with
PDoC. We also thank researchers at the University of Pennsylvania Memory
Center, Georgetown University’s Pellegrino Center for Bioethics, and Harvard

Peterson et al. BMC Med Ethics

(2021) 22:105

Page 12 of 13

Medical School’s Laboratory for Neuroimaging of Coma and Consciousness for
critical feedback.
Authors’ contributions
FW and CW designed the study. SM collected the data. LGL, SM, AP, FW, and
CW analyzed the data. AP wrote and revised the manuscript. LGL, SM, AMO,
FW, and CW commented on and edited the manuscript during the revision
process. All authors have read and approved the manuscript.

5.

6.

Funding
This research was supported by an operating grant from the Canadian
Institutes of Health Research MOP-133705. AP is currently supported by the
Greenwall Foundation Faculty Scholars program and NIH R21AG069805.
Availability of data and materials
The datasets generated and/or analyzed during the current study are not
publicly available to protect participant confidentiality but are available from
the corresponding author on reasonable request.

Declarations
Ethics and consent to participate
The Research Ethics Boards of Western University (REB #104684) and University
of Toronto (REB #30085) approved the qualitative study. George Mason Univer‑
sity’s Institutional Review Board approved qualitative data sharing for analysis
and manuscript preparation (IRB #1508398–1). All participants provided writ‑
ten informed consent. All research was performed in accordance with relevant
guidelines and regulations.
Consent for publication
Participants provided written consent to use the qualitative data in scholarly
publications and presentations. All published qualitative data are deidentified
to protect participant confidentiality.
Competing interests
CW receives consulting income from Cardialen, Eli Lilly & Company, and
Research Triangle Institute (RTI) International. All other authors have no com‑
peting interests to disclose.
Author details
1
Institute for Philosophy and Public Policy, George Mason University, Fairfax,
USA. 2 Arthur Labatt Family School of Nursing, Western University, London,
Canada. 3 Brain and Mind Institute, Western University, London, Canada.
4
Toronto Rehabilitation Institute-University Health Network, Toronoto, Canada.
5
Departments of Medicine, Epidemiology & Biostatistics, and Philosophy,
Western University, London, Canada.
Received: 22 April 2021 Accepted: 16 July 2021

7.
8.

9.
10.
11.
12.

13.

14.

15.

16.
References
1. Edlow BL, Claassen J, Schiff ND, Greer DM. Recovery from disorders of
consciousness: mechanisms, prognosis and emerging therapies. Nat Rev
Neurol. 2021;17(3):135–56. https://doi.org/10.1038/s41582-020-00428-x
(Epub 2020 Dec 14. PMID: 33318675; PMCID: PMC7734616).
2. Comanducci A, Boly M, Claassen J, De Lucia M, Gibson RM, Juan E, Lau‑
reys S, Naccache L, Owen AM, Rosanova M, et al. Clinical and advanced
neurophysiology in the prognostic and diagnostic evaluation of disorders
of consciousness: review of an IFCN-endorsed expert group. Clin Neuro‑
physiol. 2020;131(11):2736–65. https://doi.org/10.1016/j.clinph.2020.07.
015 (Epub 2020 Aug 14 PMID: 32917521).
3. Claassen J, Doyle K, Matory A, Couch C, Burger KM, Velazquez A,
Okonkwo JU, King JR, Park S, Agarwal S, et al. Detection of Brain Activa‑
tion in Unresponsive Patients with Acute Brain Injury. N Engl J Med.
2019;380(26):2497–505. https://doi.org/10.1056/NEJMoa1812757 (PMID:
31242361).
4. Beukema S, Gonzalez-Lara LE, Finoia P, Kamau E, Allanson J, Chennu S,
Gibson RM, Pickard JD, Owen AM, Cruse D. A hierarchy of event-related

17.

18.
19.

20.

potential markers of auditory processing in disorders of consciousness.
Neuroimage Clin. 2016;12:359–71. https://doi.org/10.1016/j.nicl.2016.08.
003.PMID:27595064;PMCID:PMC4995605.
Coleman MR, Davis MH, Rodd JM, Robson T, Ali A, Owen AM, Pickard JD.
Towards the routine use of brain imaging to aid the clinical diagnosis of
disorders of consciousness. Brain. 2009;132(Pt 9):2541–52. https://doi.org/
10.1093/brain/awp183 (PMID: 19710182).
Stender J, Gosseries O, Bruno MA, Charland-Verville V, Vanhaudenhuyse A,
Demertzi A, Chatelle C, Thonnard M, Thibaut A, Heine L, et al. Diagnostic
precision of PET imaging and functional MRI in disorders of conscious‑
ness: a clinical validation study. Lancet. 2014;384(9942):514–22. https://
doi.org/10.1016/S0140-6736(14)60042-8 (Epub 2014 Apr 15 PMID:
24746174).
Fernández-Espejo D, Owen AM. Detecting awareness after severe brain
injury. Nat Rev Neurosci. 2013;14(11):801–9. https://doi.org/10.1038/
nrn3608 (Epub 2013 Oct 3 PMID: 24088810).
Monti MM, Vanhaudenhuyse A, Coleman MR, Boly M, Pickard JD,
Tshibanda L, Owen AM, Laureys S. Willful modulation of brain activity in
disorders of consciousness. N Engl J Med. 2010;362(7):579–89. https://doi.
org/10.1056/NEJMoa0905370 (Epub 2010 Feb 3 PMID: 20130250).
Owen AM, Coleman MR, Boly M, Davis MH, Laureys S, Pickard JD. Detect‑
ing awareness in the vegetative state. Science. 2006;313(5792):1402.
https://doi.org/10.1126/science.1130197 (PMID: 16959998).
Peterson A, Owen AM, Karlawish J. Alive inside. Bioethics. 2020
Mar;34(3):295–305. https://doi.org/10.1111/bioe.12678 (Epub 2019 Oct
2 PMID: 31577856).
Edlow BL. Covert consciousness: searching for volitional brain activity
in the unresponsive. Curr Biol. 2018;28(23):R1345–8. https://doi.org/10.
1016/j.cub.2018.10.022 (PMID: 30513331).
Giacino JT, Katz DI, Schiff ND, Whyte J, Ashman EJ, Ashwal S, Barbano
R, Hammond FM, Laureys S, Ling GSF, et al. Practice guideline update
recommendations summary: disorders of consciousness: report of the
guideline development, dissemination, and implementation subcom‑
mittee of the american academy of neurology; the american congress
of rehabilitation medicine; and the national institute on disability,
independent living, and rehabilitation research. Arch Phys Med Rehabil.
2018;99(9):1699–709. https://doi.org/10.1016/j.apmr.2018.07.001 (Epub
2018 Aug 8 PMID: 30098791).
Kondziella D, Bender A, Diserens K, van Erp W, Estraneo A, Formisano R,
Laureys S, Naccache L, Ozturk S, Rohaut B, et al. European academy of
neurology guideline on the diagnosis of coma and other disorders of
consciousness. Eur J Neurol. 2020;27(5):741–56. https://doi.org/10.1111/
ene.14151 (Epub 2020 Feb 23 PMID: 32090418).
Fins JJ, Illes J, Bernat JL, Hirsch J, Laureys S, Murphy E. Neuroimaging and
disorders of consciousness: envisioning an ethical research agenda. Am
J Bioeth. 2008;8(9):3–12. https://doi.org/10.1080/15265160802318113
(PMID: 18853371).
Kitzinger J, Kitzinger C. The “window of opportunity” for death after severe
brain injury: family experiences. Sociol Health Illn. 2013;35(7):1095–112.
https://doi.org/10.1111/1467-9566.12020 (Epub 2012 Dec 20 PMID:
23278317).
Graham M, Weijer C, Peterson A, Naci L, Cruse D, Fernández-Espejo
D, Gonzalez-Lara L, Owen AM. Acknowledging awareness: informing
families of individual research results for patients in the vegetative state. J
Med Ethics. 2015 Jul 1;41(7):534–8.
Schembs L, Ruhfass M, Racine E, Jox RJ, Bender A, Rosenfelder M,
Kuehlmeyer K. How Does Functional Neurodiagnostics Inform Surrogate
Decision-Making for Patients with Disorders of Consciousness? A Qualita‑
tive Interview Study with Patients’ Next of Kin. Neuroethics. 2020:1–20.
doi: https://doi.org/10.1007/s12152-019-09425. Epub 2020 Jan 11.
Peterson A. How will families react to evidence of covert consciousness
in brain-injured patients? Neuroethics. 2020 Jan;4:1–4.
Weijer C, Peterson A, Webster F, Graham M, Cruse D, Fernández-Espejo
D, Gofton T, Gonzalez-Lara LE, Lazosky A, Naci L, Norton L, Speechley K,
Young B, Owen AM. Ethics of neuroimaging after serious brain injury.
BMC Med Ethics. 2014 May;20(15):41. https://doi.org/10.1186/1472-6939-
15-41.PMID:24885720;PMCID:PMC4031564.
Multi-Society Task Force on PVS. Medical aspects of the persistent vegeta‑
tive state (1). N Engl J Med. 1994;330(21):1499–508. https://doi.org/10.
1056/NEJM199405263302107 (PMID: 7818633).

Peterson et al. BMC Med Ethics

(2021) 22:105

21. Jennett B, Plum F. Persistent vegetative state after brain damage. A syn‑
drome in search of a name. Lancet. 1972; 1(7753):734–7. doi: https://doi.
org/10.1016/s0140-6736(72)90242-5. PMID: 4111204.
22. Giacino JT, Ashwal S, Childs N, Cranford R, Jennett B, Katz DI, Kelly JP,
Rosenberg JH, Whyte J, Zafonte RD, Zasler ND. The minimally conscious
state: definition and diagnostic criteria. Neurology. 2002;58(3):349–53.
https://doi.org/10.1212/wnl.58.3.349 (PMID: 11839831).
23. Posner JB, Saper CB, Schiff ND, Jan Claassen MD. Plum and Posner’s diag‑
nosis and treatment of stupor and coma. 5th ed. New York (NY): Oxford
University Press; 2019.
24. Giacino JT, Kalmar K, Whyte J. The JFK Coma Recovery Scale-Revised:
measurement characteristics and diagnostic utility. Arch Phys Med
Rehabil. 2004;85(12):2020–9. https://doi.org/10.1016/j.apmr.2004.02.033
(PMID: 15605342).
25. Naci L, Owen AM. Making every word count for nonresponsive patients.
JAMA Neurol. 2013;70(10):1235–41. https://doi.org/10.1001/jamaneurol.
2013.3686 (PMID: 23939634).
26. Gibson RM, Chennu S, Fernández-Espejo D, Naci L, Owen AM, Cruse D.
Somatosensory attention identifies both overt and covert awareness in
disorders of consciousness. Ann Neurol. 2016;80(3):412–23. https://doi.
org/10.1002/ana.24726 (Epub 2016 Aug 4 PMID: 27422169).
27. Naci L, Cusack R, Anello M, Owen AM. A common neural code for similar
conscious experiences in different individuals. Proc Natl Acad Sci U S A.
2014;111(39):14277–82. doi: https://doi.org/10.1073/pnas.1407007111.
Epub 2014 Sep 15. PMID: 25225384; PMCID: PMC4191782.
28. Glaser BG, Strauss AL. The Discovery of Grounded Theory: Strategies for
Qualitative Research. New York (NY): Routledge; 2017.
29. Munce SEP, Webster F, Christian J, Gonzalez-Lara LE, Owen AM, Weijer C.
Experiences of family of individuals in a locked in, minimally conscious
state, or vegetative state with the health care system. Brain Inj. 2021 Jan
5;35(1):8–14. https://doi.org/10.1080/02699052.2020.1858494 (Epub
2020 Dec 31 PMID: 33382636).
30. Gonzalez-Lara LE, Munce S, Christian J, Owen AM, Weijer C, Webster F. The
multiplicity of caregiving burden: a qualitative analysis of families with

Page 13 of 13

31.

32.

33.

34.

35.
36.

prolonged disorders of consciousness. Brain Inj. 2021 Jan 18;35(2):200–8.
https://doi.org/10.1080/02699052.2020.1865565 (Epub 2021 Jan 1
PMID: 33385307).
Edgar A, Kitzinger C, Kitzinger J. Interpreting chronic disorders of
consciousness: medical science and family experience. J Eval Clin Pract.
2015;21(3):374–9. doi: https://doi.org/10.1111/jep.12220. Epub 2014 Jul 4.
PMID: 24995490; PMCID: PMC4431658.
Kitzinger C, Kitzinger J. Grief, anger and despair in relatives of severely
brain injured patients: responding without pathologising. Clin Rehabil.
2014;28(7):627–31. https://doi.org/10.1177/0269215514527844 (PMID:
24920582).
Peterson A, Kostick KM, O’Brien KA, Blumenthal-Barby J. Seeing minds in
patients with disorders of consciousness. Brain Inj. 2020 Feb 23;34(3):390–
8. https://doi.org/10.1080/02699052.2019.1706000 (Epub 2019 Dec 27
PMID: 31880960).
Peterson A, Owen AM, Karlawish J. Translating the Discovery of Covert
Consciousness Into Clinical Practice. JAMA Neurol. 2020 May 1;77(5):541–
2. https://doi.org/10.1001/jamaneurol.2020.0232.PMID:32176251;PMCID:
PMC7243154.
Peterson A, Owen AM. Confronting the grey zone after severe brain
injury. Emerg Top Life Sci. 2019 Nov 27;3(6):707–11. https://doi.org/10.
1042/ETLS20190115 (PMID: 32915226).
Harkins K, Sankar P, Sperling R, Grill JD, Green RC, Johnson KA, Healy
M, Karlawish J. Development of a process to disclose amyloid imaging
results to cognitively normal older adult research participants. Alzheimers
Res Ther. 2015;7(1):26. https://doi.org/10.1186/s13195-015-0112-7.PMID:
25969699;PMCID:PMC4428104.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.

Ready to submit your research ? Choose BMC and benefit from:

• fast, convenient online submission
• thorough peer review by experienced researchers in your field
• rapid publication on acceptance
• support for research data, including large and complex data types
• gold Open Access which fosters wider collaboration and increased citations
• maximum visibility for your research: over 100M website views per year
At BMC, research is always in progress.
Learn more biomedcentral.com/submissions

